Clinical trials in Guilherand-Granges

Innovative studies focusing on hormone-sensitive breast cancer treatment optimization, particularly examining reduced therapy durations for low-risk patients.

• Hormone Therapy Duration
• Post-menopausal Treatment
• Endocrine Treatment Enhancement

Additional research explores combining everolimus with standard treatments for ER+ and HER2- breast cancer patients.

Advanced research in prostate cancer treatment, evaluating combination therapies including radiation and darolutamide for patients with oligometastatic disease.

• Metastatic Disease Management
• Radiation Therapy Optimization
• Targeted Treatment Approaches

Investigations include novel imaging techniques for precise treatment planning.

Pioneering research in chemotherapy optimization for gastrointestinal cancer patients, focusing on personalized dosing strategies.

• Enzyme Deficiency Assessment
• Toxicity Management
• Individualized Treatment Protocols

Studies aim to develop precise guidelines for patients with specific enzyme deficiencies.

Clinical investigations of squamous cell carcinoma treatments, testing new therapeutic combinations with radiotherapy.

• Post-Surgery Treatment
• Disease-Free Survival
• Novel Drug Combinations

Research focuses on improving outcomes for high-risk patients ineligible for standard treatments.